PL1802746T3 - Cząstki wirosomu zawierające antygeny wirusa grypy i wirusa zapalenia wątroby typu B - Google Patents

Cząstki wirosomu zawierające antygeny wirusa grypy i wirusa zapalenia wątroby typu B

Info

Publication number
PL1802746T3
PL1802746T3 PL05795050T PL05795050T PL1802746T3 PL 1802746 T3 PL1802746 T3 PL 1802746T3 PL 05795050 T PL05795050 T PL 05795050T PL 05795050 T PL05795050 T PL 05795050T PL 1802746 T3 PL1802746 T3 PL 1802746T3
Authority
PL
Poland
Prior art keywords
virus
hepatitis
antigens
virosome particles
influenza virus
Prior art date
Application number
PL05795050T
Other languages
English (en)
Inventor
Christian Moser
Giovanna Assero
Epifanio Fichera
Dario Ventura
Laurence Lempereur
Diana Felnerova
Original Assignee
Crucell Switzerland Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04025573A external-priority patent/EP1652914A1/en
Application filed by Crucell Switzerland Ag filed Critical Crucell Switzerland Ag
Publication of PL1802746T3 publication Critical patent/PL1802746T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL05795050T 2004-10-27 2005-10-20 Cząstki wirosomu zawierające antygeny wirusa grypy i wirusa zapalenia wątroby typu B PL1802746T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04025573A EP1652914A1 (en) 2004-10-27 2004-10-27 Virosome particles comprising antigens from influenza virus and Hepatitis B virus
PCT/EP2005/011297 WO2006045532A2 (en) 2004-10-27 2005-10-20 Virosome particles comprising antigens from influenza virus and hepatitis b virus
EP05795050A EP1802746B1 (en) 2004-10-27 2005-10-20 Virosome particles comprising antigens from influenza virus and hepatitis b virus

Publications (1)

Publication Number Publication Date
PL1802746T3 true PL1802746T3 (pl) 2011-10-31

Family

ID=38116022

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05795050T PL1802746T3 (pl) 2004-10-27 2005-10-20 Cząstki wirosomu zawierające antygeny wirusa grypy i wirusa zapalenia wątroby typu B

Country Status (3)

Country Link
US (1) US9603921B2 (pl)
EP (1) EP1802746B1 (pl)
PL (1) PL1802746T3 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120310140A1 (en) 2010-12-01 2012-12-06 Spinal Modulation, Inc. Directed delivery of agents to neural anatomy
WO2015000831A1 (en) 2013-07-02 2015-01-08 Crucell Holland B.V. Method for preparing virosomes
EP3017040B1 (en) 2013-07-02 2018-06-06 Janssen Vaccines & Prevention B.V. Method for preparing virosomes

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4624918A (en) * 1984-07-09 1986-11-25 Genentech, Inc. Purification process for hepatitis surface antigen and product thereof
EP0491077A1 (en) 1990-12-19 1992-06-24 Medeva Holdings B.V. A composition used as a therapeutic agent against chronic viral hepatic diseases
EP0538437B1 (en) 1991-05-08 1999-08-04 SCHWEIZ. SERUM- & IMPFINSTITUT BERN Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them
US5879685A (en) 1991-05-08 1999-03-09 Schweiz, Serum- & Impfinstitut Bern Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them
WO1998052603A2 (en) 1997-05-23 1998-11-26 Schweiz. Serum- & Impfinstitut Bern An influenza enveloped dna vaccine
AU662528B2 (en) 1991-05-08 1995-09-07 Schweiz. Serum- & Impfinstitut Bern New hepatitis A virus strain, method for the isolation of new hepatitis A virus strains and hepatitis A vaccines
ATE223701T1 (de) 1994-05-31 2002-09-15 Inex Pharmaceutical Corp Intrazelluläre verabreichung therapeutischer sustanzenmittels virosomen
WO1999039736A2 (en) 1998-02-03 1999-08-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem DELIVERY OF IMMUNOGENIC MOLECULES VIA HBsAg PARTICLES
US20030180351A1 (en) 1998-11-06 2003-09-25 Reinhard Gluck Pharmaceutically active composition and dispensing device
AU770225B2 (en) 1998-12-04 2004-02-19 Biogen Idec Ma Inc. HBV core antigen particles with multiple immunogenic components attached via peptide ligands
CU23002A1 (es) 2000-12-01 2004-11-18 Ct Ingenieria Genetica Biotech Método de obtención de agregados antigénicos y su uso en formulaciones
US7351413B2 (en) * 2002-02-21 2008-04-01 Lorantis, Limited Stabilized HBc chimer particles as immunogens for chronic hepatitis
BR0316402A (pt) 2002-11-21 2006-02-21 Pevion Biotech Ltd vesìcula fusogênica, métodos para preparar uma vesìcula fusogênica encapsulante, e para encapsular pelo menos uma substáncia terapêutica ou imunologicamente ativa em uma vesìcula fusogênica, uso de uma vesìcula fusogênica, e, formulação farmacêutica

Also Published As

Publication number Publication date
EP1802746B1 (en) 2011-05-04
EP1802746A2 (en) 2007-07-04
US9603921B2 (en) 2017-03-28
US20090087453A1 (en) 2009-04-02

Similar Documents

Publication Publication Date Title
SG2014012868A (en) Functional influenza virus like particles (vlps)
IL182817A0 (en) Defective influenza virus particles
ZA200800505B (en) Modified influenza virus for monitoring and improving vaccine efficiency
IL183888A (en) Method for producing replicable influenza virus particle, influenza virus particle obtained by the above method and a pharmacist's preparation containing said particle
IL200432A (en) Human antibodies against hepatitis C virus and their uses
IL186710A (en) Influenza A virus is isolated from dogs, a drug and vaccine that include it and its use
IL206156A0 (en) Antibodies against influenza virus and methods of use thereof
AU2003251604A8 (en) Viruses and virus-like particles for multiple antigen and target display
AU2003254594A1 (en) Methods and compositions for detecting sars virus and other infectious agents
EP1684787A4 (en) INHIBITORS OF HEPATITIS C VIRUS
EP1684745A4 (en) INHIBITORS OF HEPATITIS C VIRUS
AU2003227533A8 (en) Virus like particle from papillomavirus and their use in vaccine
ZA200803131B (en) Rabies virus vector systems and compositions and methods thereof
EP1622574A4 (en) EXPRESSION SYSTEMS OF RECOMBINANT PARAINFLUENZA VIRUSES AND VACCINES COMPRISING HETEROLOGOUS ANTIGENS DERIVED FROM METAPNEUMOVIRUS
IL181733A0 (en) Vaccines comprising plasmodium antigens
DK1523329T3 (da) Viruspartikeladjuvant
ZA200809056B (en) Influenza virus vaccine
ZA200803558B (en) Marked bovine viral diarrhea virus vaccines
ZA200701674B (en) Vaccine composition against Hepatitis C virus
AU2003229474A8 (en) Methods and compositions for detecting sars virus
SI1951299T1 (sl) Cepiva proti influenci, ki vkljuäśujejo kombinacije adjuvantov iz delcev in imunopotenciatorjev
PL1802746T3 (pl) Cząstki wirosomu zawierające antygeny wirusa grypy i wirusa zapalenia wątroby typu B
EP1871786A4 (en) PEPTIDE VACCINE AGAINST THE GRIPPEVIRUS
ZA200703793B (en) Defective influenza virus particles
EP1833989A4 (en) VIRUS PREPARATIONS AND METHODS